BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 18780808)

  • 1. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting adverse drug reactions on a geriatric ward: a pilot project.
    Somers A; Petrovic M; Robays H; Bogaert M
    Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A description of a successful computerized adverse drug reaction tracking program.
    Maliekal J; Thornton J
    Hosp Formul; 1990 Apr; 25(4):436-9, 442. PubMed ID: 10104234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of electronic reporting to aid surveillance of ADRs in children: a proof of concept study.
    Lynn RM; Riding K; McIntosh N
    Arch Dis Child; 2010 Apr; 95(4):262-5. PubMed ID: 20335236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.